RESUMEN
Background: People who inject drugs (PWID) are at high risk of contracting blood-borne infections. Many developed countries started a needle exchange program to provide PWID with sterile syringes. In Sudan, healthcare professionals are exposed to legal liability if they cooperate with people who use drugs; therefore, the accessibility to sterile syringes without prescription depends heavily on pharmacists' knowledge and attitude toward PWID.Objectives: Assessing policy, practice, and perceptions of pharmacists toward selling sterile syringes to PWID in Khartoum, Sudan.Methods: A self-administered questionnaire was given to 157 pharmacists (57 male, 100 female).Results: Out of 157 participating pharmacists, 86.6% reported selling syringes without a medical prescription, 53.5% inquired about the reason for buying syringes, and 87.9% refused to sell the syringes to a PWID. 43.3% of participating pharmacists were uncertain about the presence of law to regulate selling syringes without prescriptions. Although 47.7% of the participants agreed that selling empty syringes without a medical prescription to PWID will reduce harm, 68.5% will not sell them to PWID without a medical prescription even if it is encouraged by law due to their religious or moral beliefs.Conclusion: Pharmacists are the main providers of clean syringes for PWID in Khartoum, Sudan. With the majority of them reporting refusal to provide syringes to PWID, this may put PWID at higher risk of contracting blood-borne infections due syringe sharing. This is a challenge to overcome in planning for effective harm reduction programs in Khartoum.
Asunto(s)
Consumidores de Drogas , Infecciones por VIH , Farmacia , Abuso de Sustancias por Vía Intravenosa , Actitud del Personal de Salud , Infecciones de Transmisión Sanguínea , Femenino , Humanos , Masculino , Programas de Intercambio de Agujas , Políticas , Sudán , JeringasRESUMEN
Objective: This study investigated the relationship of fetuin-A with coronary calcification, carotid atherosclerosis, and mortality risk in non-dialysis chronic kidney disease (CKD). Methods: The study included 135 adult patients with CKD at stages 3-5, who were divided into coronary artery calcification (CAC) and non-CAC groups. We excluded current smokers and individuals with diabetes mellitus, inflammatory conditions, liver diseases, acute kidney failure, chronic hemodialysis, and cancer. We conducted kidney function tests, complete blood counts, and measured serum levels of fetuin-A, tumor necrosis factor-alpha (TNF-α), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), total cholesterol (TC), total triglycerides (TG), high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. Cardiac spiral computed tomography was used to calculate the CAC score, employing the Agatston method. Carotid ultrasonography was performed to assess carotid intima-media thickness (CIMT) and to detect the presence of plaques. Results: CAC patients had considerably higher levels of TNF-α (p<0.001), IL-6 (p<0.001), hs-CRP (p=0.006), TC, TG, parathyroid hormone (PTH) (p<0.001) and phosphorus (p<0.001) than non-CAC patients. They also had significantly lower levels of fetuin-A (p<0.001). Fetuin-A was considerably lower in CKD subgroups as CKD progressed. Fetuin-A (p=0.046), age (p=0.009), TNF-α (p=0.027), IL-6 (p=0.005), TG (p=0.002), PTH (p=0.002), and phosphorus (p=0.004) were significant predictors of CAC. CAC and fetuin-A were strong predictors of all-cause mortality and cardiovascular (CV) mortality. Fetuin-A was a significant predictor of CIMT (p=0.045). Conclusion: Fetuin-A reliably predicted CAC and CIMT. Fetuin-A and CAC emerged as significant risk factors for all-cause and CV mortality in non-dialysis CKD.
RESUMEN
Cold agglutinin hemolytic anemia (cAHA) is a rare autoimmune disorder characterized by the production of cold agglutinins. We present a case of secondary cAHA in a 23-year-old female with severe anemia and unexplained hemolysis. The patient exhibited findings indicative of hemolysis and a positive direct antiglobulin test (DAT) with complement alone. Additional investigations revealed incidental lung infiltrates, negative serology for infections and autoimmune diseases, and a low cold agglutinin titer. The patient showed a favorable response to doxycycline and supportive therapy, including multiple packed red blood cell transfusions. At the two-week follow-up, the patient had a stable hemoglobin level with no evidence of ongoing hemolysis. This case highlights the importance of considering secondary cAHA in patients with cold symptoms or unexplained hemolysis. Primary cAHA patients may require more aggressive treatment, including rituximab and sutilumab.
RESUMEN
INTRODUCTION: There is no evidence on the role of Human Anti Nucleolus Antibody (ANCAb) in type 2 diabetes mellitus (T2DM). We compared prevalence and concentration of ANCAb between age and a gender-matched sample of T2DM with and without diabetes-related complications. METHODS: In this study, the reaction to ANCAb was compared quantitatively between 38 T2DM patients complicated with microvascular conditions and 43 T2DM without complications as controls. RESULTS: The patients in complicated and non-complicated groups were comparable in diabetes duration (9.0 vs. 5.0 years; P = 0.065), respectively. The study found that 27 cases (71.1%) of the complicated group reacted to ANCAb test compared to 25 (58.1%) in non-complicated patients (P = 0.226; 3.53 vs. 2.72 ng/mL; P = 0.413). The reaction response to ANCAb in patients with neuropathy and cardiovascular complications was 80.0%, 76.2% in patients with neuropathy compared to 58.1% in the control group (P = 0.398). The reaction response to ANCAb in patients with mono-complication was 72.7% compared 68.8% in patients with multi-complication (P = 0.466). Similarly, 76.2% of patients with T2DM and complicated with neuropathy (n = 21 patients) reacted to ANCAb compared to 58.1% in control patients with (P = 0.158). CONCLUSIONS: Reaction to ANCAb was not statistically different between the T2DM patients with and without complications.
Asunto(s)
Autoanticuerpos/sangre , Nucléolo Celular/inmunología , Diabetes Mellitus Tipo 2/sangre , Angiopatías Diabéticas/sangre , Neuropatías Diabéticas/sangre , Adulto , Autoanticuerpos/inmunología , Biomarcadores/sangre , Diabetes Mellitus Tipo 2/complicaciones , Femenino , Humanos , Persona de Mediana EdadRESUMEN
Background Irisin, a hormone-like myokine, is suspected to have a role in metabolic syndrome (MetS) through regulating energy homeostasis and mediating physical activity. In this regard, the role of irisin and malondialdehyde (MDA) along with some other biochemical parameters in the prediction of MetS was examined in the present investigation. Materials and methods In the present case-control study, 36 subjects diagnosed with MetS according to International Diabetes Federation were considered as cases and were matched in age and gender with 31 healthy participants. The difference of biochemical indicators between cases and controls were determined whether by independent t-test or the Mann-Whitney U-test. The predictors of MetS and insulin resistance (IR) were examined through logistic and linear regressions analysis models, respectively. Results Irisin and MDA were not found to be predictors for MetS in logistic regression; p = 0.258 and p = 0.694, respectively. The IR was found to be the only direct predictor of MetS (p = 0.010). Similarly, in linear regression, irisin and MDA were not identified to be predictors for IR; p = 0.801 and p = 0.781, respectively. Conclusions The study did not show that irisin and MDA, directly and indirectly, were predictors of MetS disorder. The IR was only predictor of MetS.
Asunto(s)
Fibronectinas/metabolismo , Síndrome Metabólico/etiología , Síndrome Metabólico/metabolismo , Estrés Oxidativo , Adulto , Biomarcadores , Índice de Masa Corporal , Estudios de Casos y Controles , Femenino , Glucosa/metabolismo , Humanos , Resistencia a la Insulina , Masculino , Síndrome Metabólico/diagnóstico , Persona de Mediana Edad , Factores de Riesgo , Adulto JovenRESUMEN
AIMS: Recently, it was suggested that betatrophin has a role in controlling pancreatic ß cell proliferation and lipid metabolism, however, its role in human subjects has not been established yet. The predicting role of betatrophin and MDA along with other biochemical indicators in type 2 diabetes mellitus (T2DM) in a sample of the Iraqi population was examined in the present investigation. METHODS: A total of 31 patients diagnosed with T2DM and 30 adult subjects without diabetes were matched in age and gender in a case-control study. Logistic and linear regression models were performed to examine the role of MDA and betatrophin in T2DM and triglyceride, respectively. RESULTS: The study confirmed a higher concentration of LDL (124.45 vs. 102.70â¯mg/dL; Pâ¯=â¯.001) and TG (191.13 vs. 103.83â¯mg/dL; Pâ¯<â¯.0001), insulin (18.40 vs. 10.97 µU/mL; Pâ¯<â¯.0001), and Hs. CRP (5.39 vs. 2.80â¯mg/L; Pâ¯=â¯.033) in diabetic patients compared to the controls. No significant difference in betatrophin and MDA was found between diabetic patients and non-diabetic healthy subjects. The study showed triglyceride as the only predictor of T2DM (Pâ¯=â¯.028). Similarly, total cholesterol (Pâ¯<â¯.0001), HDL (Pâ¯=â¯.001), LDL (Pâ¯<â¯.0003), and MDA (Pâ¯=â¯.010) were shown as predictors of triglyceride in diabetic patients. CONCLUSION: The present study that triglyceride is a direct and MDA is an indirect predictor for T2DM.